chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt Hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt Hot) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no medical history was provided by reporter.     On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced FEELING HOT (Felt Hot). On 24-Apr-2021, FEELING HOT (Felt Hot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, SARS-CoV-2 test positive: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided
01/19/21 10 PM: Redness, warmth, tenderness, itchiness, swelling to injection site, affected area under 2 inches in diameter.  Took Benedryl 50 mg and Ibuprofen 800 mg. Took Ibuprofen 800 mg about 8 hours later, took Ibuprofen 600 mg about 8 hours later, took Ibuprofen 600 mg and benedryl 50 mg, took ibuprofen 400 mg about 8 hours later, took Benedryl 25 mg at bedtime. 01/21/21 12AM: Redness fading, swelling almost back to baseline, no tenderness, no itchiness. 01/26/21 10 AM: Itchiness present, dark pink injection site under 2 inches in diameter 01/26/21 8:30 PM - 8 Days post injection: Redness, warmth, itchiness, swelling to injection site, affected area just over 2 inches (2 2/8ths inches) in diameter. Took Benedryl 50 mg and Ibuprofen 800 mg. Center of injection site reading at 100.4°F via iHealth no-touch infrared forehead thermometer. An inch above read 96.9°F, an inch below read 96.9°F, my forehead read 98.4°F all temps within seconds of the previous reading. Took Benedryl 50 mg and Ibuprofen 800 mg.
aches; Fever; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (aches), PYREXIA (Fever), CHILLS (chills) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 025B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), AMLODIPINE, ROSUVASTATIN and FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-May-2021, the patient experienced MYALGIA (aches), PYREXIA (Fever), CHILLS (chills) and HEADACHE (headache). On 07-May-2021, MYALGIA (aches), PYREXIA (Fever), CHILLS (chills) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information were not provided.
Had 1 st dose Moderna 1/15/2021.immediately, in the next 4 days, she experienced, pain at the vacc. site, fatigue and Flu-like sx. The 5 days after: She had extreme fatigue, severe lightheadedness, like drifting away. She had repetitive, pulsating sharp chest pains, left-sided, lasting 5-8 sec., stop and then return 10-30 minutes later. Not nocturnal. Had some BP variations, low HR noted in the 48-50 beats /min. Diastolic BP in the 60's. She had the second dose of Moderna 2/12/2021. The same sx of odd heart sensation with pilsating chest pains, excessive fatigue were there. Had pulsating chest pains for about 5 days after the vaccine. With the 3rd dose of Moderna, she had COVID arm x 2 weeks. The 4th dose, was the 4th dose of Moderna caused similar sx as COVID arm, but less intense and lasted 7-8 days.
patient was given her second dose of pfizer covid 19 (5-11) without the vaccine being diluted properly
Flu-like symptoms; pain at injection site and radiating to hand and upper back; limited range of motion; redness, swelling, approximately 5"; nausea and diarrhea.
Red swollen painful feverish injection site.  Febrile 100.0, dizziness, headache,  severe bone pain worse in the lower back and pelvic region. Cold like symptoms and swollen lips with blood blisters. Also right arm is swollen from shoulder to elbow
Patient is a 60 y.o. female patient of MD with history of long QT syndrome s/p dual-chamber ICD insertion and failure with new insertion of an ICD on November 2022., paroxysmal A-fib, factor V Leyden deficiency, presented to Hospital with right-sided weakness,   Fever and cough for 3 days   Covid 19 Fever Chest x-ray-Lungs are free of focal infiltrates CRP-9.0 Sedrate-36 Blood Cx-no growth Urine Cx-no growth Urinalysis -negative ID following Remdesivir IV-completed 3 doses Decadron 6 mg oral daily-completed Albuterol inhalers prn Oxygen as needed     Right-sided weakness Acute CVA CT head- negative Right shoulder x-ray- negative  Neurology signed off- follow up outpatient for EMG PT/OT CTA head/neck-negative Continue ASA   A-fib Long QT syndrome S/p dual-chamber ICD insertion 2005, removed in 2012 due to failure Last echo in 2022 showed LVEF of 75%, enlarged LA, Continue metoprolol, ASA A-fib Long QT syndrome S/p dual-chamber ICD insertion 2005, removed in 2012 due to failure Last echo in 2022 showed LVEF of 75%, enlarged LA, Continue metoprolol, ASA     Factor V Leiden deficiency Patient is following with an outpatient physician Monitor for now for any signs of bleeding   Hypertension Hold amlodipine start metoprolol and spironolactone
I started having ear ringing after receiving the J&J vaccine in March 2021. The ringing was on and off for months then seemed to temporarily subside, but has since returned. I should note that within the time it had subsided, I received a booster, this time the Pfizer on 10/25/21. And the ringing has returned since then. The ringing is intermittent and very high pitched. I would describe it as the sensation of ?background noise.?  It has definitely caused increased anxiety for me and I hope that reporting helps find any existing connection so others don?t have to experience it.
Information has been received from a consumer via the internet reporting that she knew of toddlers who on an unspecified dates were vaccinated with MMR II. It was reported that the toddlers had seizures followed by regression into autism accompanied by inflammatory bowel disease after receiving the vaccination. The outcome was not provided at this time. It was not specified if the patients sought medical attention or not. Upon internal review, seizure and autism were considered to be other important medical events. This is one of several reports received from the same source. Attempts are being made to verify the existence of the identifiable patients.
PATIENT REPORTS REDNESS, PAIN, & SWELLING AT SITE OF INJECTION WITH FLU LIKE SYMPTOMS X 3 DAYS.
The patient reported that her arm felt fine after her shot until around bedtime last evening, when it got so sore and painful that she could not lift it at all; she said she could only move her hand a little.  She took an Aleve and went to bed.  When she got up this morning it was still very painful and she could not lift it.  She took another Aleve but it did not help.  I asked if it was red or swollen and she stated she could not even take her arm out of her blouse to look.  I contacted her primary care physician, who advised that she go to the walk-in clinic.  The patient did so, and I talked to her after.  She said the doctor told her there was a little swelling but no redness, and an X-ray of her shoulder showed nothing that would have been caused by the shot.  The doctor concluded it was a bad reaction to the shot.  She was given 2 Tylenol and advised to use cold compresses to help with the discomfort.  If she has any other issues she is to follow up with her primary care physician.
Nausea from Flu shot given a week ago HP joints sore. Top arm of injection site is sore (not injection site).
Medication expired on 4/2/2023 and was given on 4/6/2023.
pt recv vax 25JUL96 & 27JUL96 pt devel flushing & exp a h/a;On 27JUL96 pt devel hives & went to the  ER:pt recovered from he hives by 29JUL96;MD dx pt sx as allerg rxn to the vax;
Resident received 2nd dose of vaccine 2/13/2021.  During routine testing, resident tested positive for COVID-19 on 3/8/2021 - 24 days out from vaccine date.  Resident is asymptomatic.  This resident was a previous COVID positive on 11/30/2020 and had just started retesting this month.
Vaccinee (Case #1) rec'd a 1st Engerix-B vax (third in Hepatitis B vax series) in lt deltoid on 1JAN90; Testing on 19FEB90 indicated did not seroconvert;
Patient described that she felt that she was going to "pass out". Immediate vitals taken showing bradycardia and hypotension. Patient states that she only drank coffee prior to arrival and she usually passes out s/p blood draws and vaccines. Patient was given water and food. Patient remained conscious throughout episode. No LOC, n/v, chest pain, sob, feeling of throat closing. Patient placed supine and given additional oral fluids. BP improved to 99/61, HR 50, O2 100%.
Elevated BP. Normal prior to shot; detected elevated day after shot. Values have ranged from 170/90 to 208/110. Norvasc prescribed on 11/20/2002. Moderate edema of face and neck. Lasted about 5 days. Excess gas, flatulence. Lasted about 5 days. Shortness of breath, decreased ability to exercise. Symptoms reduced considerably over 5-10 days.
Urticaria at injection site - Pruritus of conjunctiva.  Gave 25mg of Benadryl intramuscularly and Benadryl cream.
Parent brought child to hospital c/o soreness and swelling to shot (Flu) site, approx 2 1/2 hrs post immunization. Site with 2 inches size in diameter according to mom. No other symptoms. ER Dr ordered BENADRYL.
Feeling tired between Moderna Covid-19 vaccinations; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FATIGUE (Feeling tired between Moderna Covid-19 vaccinations) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Feeling tired between Moderna Covid-19 vaccinations). At the time of the report, FATIGUE (Feeling tired between Moderna Covid-19 vaccinations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported. The patient takes Methotrexate for a medical condition that requires an immune suppressant. The patients Doctor asked him to stop taking the methotrexate 1 week before the first vaccination and 2 weeks after the second vaccination with no doses in between vaccinations No treatment medications reported.
Welts to lower extremity evening on the day of vaccination. Systemic rash 4 days later with severe itching.
migraine; feeling very faint; feeling very lightheaded; fever of 101.7; aches; no chills but she was cold all day and the next day; could not warm up; Sore arm; sore and hurts when she touches her arm; Arm red at the injection site and below injection site; headache that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), NASOPHARYNGITIS (no chills but she was cold all day and the next day), VACCINATION SITE WARMTH (could not warm up), MIGRAINE (migraine) and PRESYNCOPE (feeling very faint) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN, FISH OIL, CALCIUM, MULTIVITAMIN [VITAMINS NOS], CURCUMIN (THERACURMIN BIOACTIVE), MENAQUINONE-7 (VITAMIN K 2) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (aches), NASOPHARYNGITIS (no chills but she was cold all day and the next day), VACCINATION SITE WARMTH (could not warm up), PAIN IN EXTREMITY (Sore arm), MYALGIA (sore and hurts when she touches her arm), VACCINATION SITE ERYTHEMA (Arm red at the injection site and below injection site) and HEADACHE (headache that comes and goes). On 27-Feb-2021, the patient experienced PYREXIA (fever of 101.7). On 02-Mar-2021, the patient experienced MIGRAINE (migraine), PRESYNCOPE (feeling very faint) and DIZZINESS (feeling very lightheaded). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (aches), NASOPHARYNGITIS (no chills but she was cold all day and the next day), VACCINATION SITE WARMTH (could not warm up), MIGRAINE (migraine), PRESYNCOPE (feeling very faint), DIZZINESS (feeling very lightheaded), PAIN IN EXTREMITY (Sore arm), MYALGIA (sore and hurts when she touches her arm), VACCINATION SITE ERYTHEMA (Arm red at the injection site and below injection site), HEADACHE (headache that comes and goes) and PYREXIA (fever of 101.7) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 101.7 (High) increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: According to the TCR report received on 09-JUN-2021, patient took the second dose on an unknown date. so action taken was changed from unknown to not applicable and outcome of all the events were updated from unknown to resolved and captured the history of COVID-19 which was missed to capture in initial version.
This spontaneous report has been received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-MAY-2017, the patient was vaccinated with expired dose of M-M-R II lot # L009213, expiration date 17-MAR-2017 (dose and route of administration were not reported) reconstituted with sterile diluent (MRK) lot # reported as L014262, expiration date 17-FEB-2018 (dose and route of administration were not reported). Vaccine was supported via post-expiry memo. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Patient walked to th chair for observation, within a minute patient leans forward then fell over chair to his right and landed on face. I(pharmacist) ran to his side, I though he was having a seizure ,yelled to my technician to call 911 , but with further assesment I knew he didnt have a seizure, he fell on his face and his arms tucked under his abdomen, so he couldn't lift himself up properly. I sat him up,he was responsive to my questions, pulse was very faint and he started to sweat,pale,clammy . His nose was bleeding from the fall. Within 9 minutes paramedic showed up , took blood pressure and glucose check. After assesment they didn't feel it was necessary to go to emergency room. Patient didn't eat breakfast,got him apple juice and chocolate. This never happened to him before. His friend came to meet him and make sure he was ok, he left voluntarily ,and back to himself.
This spontaneous report was received from a registered nurse concerning to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of both VARIVAX lot # N017700, expiry date 09-JUN-2019 or lot # N023960, expiry date: 01-SEP-2019 and M-M-R II lot # N009800, expiry date: 24-MAR-2018, lot # N013280, expiry date: 28-APR-2019 or lot # N034411, expiry date: 04-DEC-2019 for prophylaxis (strength, dose, frequency, route and anatomical location were not provided). It was unknown which of the lots of VARIVAX and M-M-R II were administered to the patient. Also, the nurse reported that sterile diluent(MERCK) used for reconstitution of vaccines was properly stored. No adverse effects reported. The temperature excursion and time frame for VARIVAX was between -14 degree C to -10 degree C (-9.9 degree C) for a time frame of 3 hours and 57 minutes and for M-M-R II was between 9 degree C to 25 degree C (13.4 degree C) for a time frame of 2 hours and 36 minutes. No previous temperature excursion was reported. Data logger was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA004192: US-009507513-1808USA004220: US-009507513-1808USA004217: US-009507513-1808USA004218: US-009507513-1808USA004219.
At site of injection hot and tender... headache, body chills over all malaise, patient continues every day having episodes of general malaise and severe headaches.  Doctor ordered blood tests results negative.
Narrative:  Pt given second shingrix on 5/6/21 @ 11:07. Received #1 on 12/15/20. Went home after 2nd vaccine and friends brought himback to facility due to severe left arm pain and swelling. Also stating that he was having difficulty breathing, increased anxiety, and increased dizziness secondary to the pain he was experiencing. Was given ice pack to area. EVAC was called, and he was transported to Hospital ER. Also given Tylenol. Pt called by RN on 5/7 and stated that he was discharged from hospital without prescriptions. Pt takes extra strength Tylenol.
Redness and swelling to (L) thigh around injection site 24 hours after immunization. Treated with Clindamycin for possible cellulitis by Dr.
Patient noticed after 1 wk. she had a quarter (1") size rash not going away for few days. She came to store/pharmacy on 10-16-16. When she put ice, doesn't itch much but redness still there. Store/pharmacy contact Doctor's office, MD ask us to instruct patient call MD any time if she has concerns or condition get worse. Also report to Merck by phone.
11/15/07 Received PPV 23 vaccine RD at flu clinic which ran from 3-5:30pm. At 6pm 11/15/07 client states pain (L) arm at injection site with chills-skaes 11/16/07 c/o Temp 100.1 with nausea no vomiting. Called primary MD (I) heat-ice and ibuprofen. No Ibuprofen taken. Took Demerol-Vicodin instead used ice on and off.
POTENTIALLY EXPIRED DOSE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 50 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 30-APR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 30-APR-2021, the subject experienced expired dose administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired dose administered was not reported. This report was non-serious.
Severe left Bell's palsy started 9 days after the 2nd Shingrix injection.
Itchiness w/ in a few minutes of injection. Developed indurated lump of 3inches, hot to touch. As of 03-30-21 site still indurated 2 inches, warm to the touch and ongoing itchiness.
I have been having dizzy spells for years but they are getting worse and more frequent. Especially the last 2 years. I did not relate this to the vaccine but now I am wondering if it is flaring it up. I have had a heart monitor on from my doctor, to record. They recorded 17 seconds recently of abid. They also did a stress test on me and that came out fine, and I was referred to a different doctor now about this.
H/A chills, fever, malaise, then migraines. Then 1-2 migraine  H/A every day.  No H/A for the past 36 hours.  Went to see pcp.
30 year old Female received her first dose of Pfizer Vaccine approximately @ 1211 (Lot #: ER8732 exp 03/24/2021 @ 1045).  Patient sat in EMT observation area for 25 minutes, then she reported having a tingling tongue and throat at 1236.  EMT sat patient down in zero-gravity chair and started to assess patient,  RN recorded incident and assisted with assessment. No sign of swelling in tongue and throat upon EMT assessment.  Patient was given water and assessed her medical history,  Patient stated that she has an allergy to peanuts and has Asthma, for which she carries an Epi-pen and inhaler on her person. First set of vitals at 1239 (RR 20, HR 96, O2 Sat 98%, unable to assess BP (Large cuff broke- used EMT?s BP Cuff for following BPs). At 1245, patient stated she continues to have tingling on her tongue and throat. Pt offered Benadryl and agreed. At 1250,  RN administered 50mg PO Benadryl. Patient was educated of potential side effect of drowsiness with medication. Patient stated she would call her mom or roommate to pick her up. At 1255, vitals reported: (RR 14, HR 96, O2 Sat 97%, Left forearm BP 140/70). Patient stated blood pressure is in her normal range (Patient stated her previous reading was 137/79 last month). At 1257, patient stated she is feeling better and was singing along to the songs playing on the radio. At 1305, assessed vitals: (RR 16, HR 95, O2 Sat 97%, Left forearm BP 144/66). Patient stated she has no more tingling on her tongue or throat. At 1307, patient stood up and sat on a chair near the exit to wait for her roommate. At 1320, roommate picked up patient. Patient left site in stable condition and was alert and oriented x4 with a steady gait.
vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 06Jul2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 06Jul2022) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 06Jul2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 06Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 06Jul2022).    No concomitant medication information was reported. Patient received half dose. The vial was initially stored in refrigerator on 04-Jun-2022. The vial did not undergo any temperature excursions. No treatment information was reported.